Flagship Harbor Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-140
Closed -$3K – 1939
2018
Q4
$3K Hold
140
– – ﹤0.01% 1580
2018
Q3
$5K Sell
140
-285
-67% -$10.8K ﹤0.01% 1706
2018
Q2
$15K Buy
+425
New +$15.4K ﹤0.01% 1222

Other funds holding SBIO

Flagship Harbor Advisors's SBIO Position: Q1 2019 in Review

Flagship Harbor Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2019, closing a stake of 140 shares — an estimated $3K sold.

Flagship Harbor Advisors first reported a position in SBIO in Q2 2018 and held it in 3 quarters. The position peaked at $15K in Q2 2018. 47 funds tracked by Wall St. Rank hold SBIO as of Q1 2019.

  • Flagship Harbor Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2019 after selling out during the quarter.
  • Flagship Harbor Advisors sold 140 ALPS Medical Breakthroughs ETF shares in Q1 2019, an estimated $3K.
  • Flagship Harbor Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q2 2018 and held it in 3 quarters.
  • Flagship Harbor Advisors's ALPS Medical Breakthroughs ETF position peaked at $15K in Q2 2018.
  • 47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2019.

Based on Flagship Harbor Advisors's 13F filing for Q1 2019, filed 15 Apr 2019.